Anders Helldén
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in ⓘ
-
- Pharmacovigilance and Adverse Drug Reactions 2
-
- Pharmacogenetics and Drug Metabolism 4
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Ingegerd Odar‐Cederlöf (9 shared papers)Ulf Bergman (7 shared papers)Lars Ståhle (3 shared papers)Jan‐Olof Svensson (2 shared papers)Gunnar Öhlén (3 shared papers)Mia von Euler (3 shared papers)Jan Lycke (2 shared papers)Juliette Säwe (1 shared paper)
In The Last Decade
Anders Helldén
22 papers receiving 402 citations
Peers
Comparison fields: 5 of 81
- Geriatrics and Gerontology 67
- Toxicology 37
- Family Practice 19
- Internal Medicine 22
- Pharmacology 45
Countries citing papers authored by Anders Helldén
This map shows the geographic impact of Anders Helldén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Helldén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Helldén more than expected).
Fields of papers citing papers by Anders Helldén
This network shows the impact of papers produced by Anders Helldén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Helldén. The network helps show where Anders Helldén may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Helldén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 76 | |
| 2 | 2009 | 65 | |
| 3 | 2006 | 55 | |
| 4 | 2008 | 36 | |
| 5 | 2013 | 32 | |
| 6 | [Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study]. | 2008 | 20 |
| 7 | 2019 | 16 | |
| 8 | 2012 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2007 | 11 | |
| 11 | 2015 | 10 | |
| 12 | 2021 | 10 | |
| 13 | 2013 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 2010 | 9 | |
| 16 | 2015 | 9 | |
| 17 | 2019 | 7 | |
| 18 | 2013 | 5 | |
| 19 | 2014 | 5 | |
| 20 | 2012 | 3 |
About Anders Helldén
Anders Helldén is a scholar working on Toxicology, Pharmacology, Geriatrics and Gerontology, Internal Medicine and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 417 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (7 papers), Cytomegalovirus and herpesvirus research (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Geriatrics and Gerontology (67 citations), Toxicology (37 citations), Family Practice (19 citations), Internal Medicine (22 citations) and Pharmacology (45 citations). Anders Helldén has collaborated with scholars based in Sweden, Canada and Malaysia. Frequent co-authors include Ingegerd Odar‐Cederlöf, Ulf Bergman, Lars Ståhle, Jan‐Olof Svensson, Gunnar Öhlén, Mia von Euler, Jan Lycke, Juliette Säwe, Lisbeth Barkholt and Charlotte Medin. Their work appears in journals such as European Journal of Clinical Pharmacology, BMJ Open, Nephrology Dialysis Transplantation, Journal of Antimicrobial Chemotherapy and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.